Literature DB >> 19740122

Hyperinsulinaemia in migraineurs is associated with nitric oxide stress.

H-J Gruber1, C Bernecker, S Pailer, G Fauler, R Horejsi, R Möller, A Lechner, F Fazekas, M Truschnig-Wilders.   

Abstract

There is growing evidence that alterations in the insulin and glucose metabolism may be involved in the pathogenesis of migraine. Nitric oxide (NO) stress has been associated with migraine. However, the role of NO on the insulin and glucose metabolism in migraineurs has remained elusive to date. The aim of the present study was to investigate the insulin and glucose metabolism in migraineurs and to determine possible interactions with the NO pathway. One hundred and twenty non-obese probands participated in this study, including 48 migraineurs and 72 healthy volunteers. Various parameters of the NO pathway, glucose metabolism as well as body measurement parameters were determined. We found a highly significantly increased insulin and Homeostasis Model Assessment (HOMA)-index in migraine patients, whereas fasting glucose was decreased. Logistic regression revealed an odds ratio of 5.67 for migraine, when comparing the lowest with the highest quartile of HOMA. Multivariate analysis showed that HOMA, waist-to-length ratio and nitrite as parameters of NO stress were highly significantly correlated. We show here that hyperinsulinaemia is associated with migraine and, furthermore, is correlated with increased NO stress. These findings represent a new pathophysiological mechanism that may be of clinical relevance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19740122     DOI: 10.1111/j.1468-2982.2009.02012.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  7 in total

1.  Non-alcoholic fatty liver disease in patients with migraine.

Authors:  Asuman Celikbilek; Mehmet Celikbilek; Aylin Okur; Serkan Dogan; Elif Borekci; Mustafa Kozan; Sebnem Gursoy
Journal:  Neurol Sci       Date:  2014-04-23       Impact factor: 3.307

Review 2.  Glucose-Related Traits and Risk of Migraine-A Potential Mechanism and Treatment Consideration.

Authors:  Md Rafiqul Islam; Dale R Nyholt
Journal:  Genes (Basel)       Date:  2022-04-22       Impact factor: 4.141

Review 3.  Is Migraine Primarily a Metaboloendocrine Disorder?

Authors:  Innocenzo Rainero; Flora Govone; Annalisa Gai; Alessandro Vacca; Elisa Rubino
Journal:  Curr Pain Headache Rep       Date:  2018-04-04

4.  Migraine, cerebrovascular disease and the metabolic syndrome.

Authors:  Alexandra J Sinclair; Manjit Matharu
Journal:  Ann Indian Acad Neurol       Date:  2012-08       Impact factor: 1.383

5.  Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine.

Authors:  Ertugrul Uzar; Osman Evliyaoglu; Gülten Toprak; Abdullah Acar; Yavuz Yucel; Tugba Calisir; Mehmet Ugur Cevik; Nebahat Tasdemir
Journal:  J Headache Pain       Date:  2011-02-27       Impact factor: 7.277

6.  A Digital Therapeutic Allowing a Personalized Low-Glycemic Nutrition for the Prophylaxis of Migraine: Real World Data from Two Prospective Studies.

Authors:  Vivian Valeska Lelleck; Franziska Schulz; Oliver Witt; Gianna Kühn; Dominik Klein; Astrid Gendolla; Stefan Evers; Charly Gaul; Diamant Thaçi; Christian Sina; Torsten Schröder
Journal:  Nutrients       Date:  2022-07-17       Impact factor: 6.706

Review 7.  New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters?

Authors:  Claudio Tana; Emmanuele Tafuri; Marco Tana; Paolo Martelletti; Andrea Negro; Giannapia Affaitati; Alessandra Fabrizio; Raffaele Costantini; Andrea Mezzetti; Maria Adele Giamberardino
Journal:  J Headache Pain       Date:  2013-02-01       Impact factor: 7.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.